Regenxbio (RGNX) Competitor Comparison
We are evaluating the key criteria listed to compare Regenxbio (RGNX) against its competitors in the Biotechnology industry.
Market Capitalization
134 / 368Gross Profits
262 / 278Total Revenue
91 / 300EBITDA
297 / 337Free Cashflow
310 / 352Quick Ratio
265 / 357Earnings per Share
298 / 359Dividend yield
0 / 6Total Cash
112 / 358Performance 3 years
199 / 368Performance 5 years
211 / 368Performance 10 years
172 / 368Linearity 3 years
125 / 368Linearity 5 years
141 / 368Linearity 10 years
85 / 368Total Rank
247 / 368Dividend Rank
32 / 368Valuation Rank
226 / 368Piotroski Rank
308 / 368Muliplier Rank
193 / 368EBITDA - RGNX ranking 297 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.